Universal Digital Announces the Filing of Amended and Restated Financial Statements and MD&A’s 
Victory Square Technologies Reports Q2 2025 Results Highlighted by Revenue Growth, Profitability, and Portfolio Momentum 
American Aires Inc. Announces Business Continuity and Governance Actions Following Special Committee Review 
Zeebu Reaches $10 Billion Settlement Milestone, Proves Programmable Payments Are Production-Ready Notice of Saniona AB extraordinary shareholders’ meeting
PRESS RELEASE May 26, 2021 The English text is an unofficial translation. In case of…
AB Science communicates results from Phase 3 study evaluating masitinib in prostate cancer
PRESS RELEASE AB SCIENCE COMMUNICATES RESULTS FROM PHASE 3 STUDY EVALUATING MASITINIB IN PROSTATE CANCER…
Bulletin from the Saniona AB annual shareholders’ meeting on May 26, 2021, and information regarding planned extraordinary shareholders’ meeting
PRESS RELEASE May 26, 2021 Today, on May 26, 2021, the annual shareholders’ meeting was…
CancerVAX Announces Research Program to Develop Its First Immunotherapy Cancer Treatment
The Company has entered into an agreement with UCLA to develop an immunotherapy breakthrough targeted…
Olainfarm invites to First Quarter 2021 Investor Conference Webinar
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor…
Novome Biotechnologies Appoints Dr. David N. Cook and Zachary Hornby to its Board of Directors
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Novome Biotechnologies, Inc., a biotechnology…
AIM ImmunoTech Announces Positive Safety Data from the Third Cohort of Its Phase 1 Intranasal Clinical Trial
OCALA, Fla., May 26, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today…
Rafael Pharmaceuticals to Present New Pancreatic Cancer and Biliary Tract Cancer Data featuring CPI-613® (Devimistat) at the American Society of Clinical Oncology (ASCO) 2021 Virtual Scientific Program
CRANBURY, N.J., May 26, 2021 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”),…
Kymera Therapeutics Presents New Data Demonstrating Proof-of-Degradation Using Novel Tissue-Restricted E3 Ligase
Novel E3 ligase identified by Kymera’s Whole-Body Atlas is expressed in selected tissues while broadly…
AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on SPX-1009 Compound Proving Suppression of Melanoma Cells
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM”…
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
EWING, N.J., May 26, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Albireo to Present at Upcoming Jefferies and William Blair Virtual Investor Conferences
BOSTON, May 26, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver…
Bellerophon Appoints Naseem Amin, M.D. as Chairman of its Board of Directors
Dr. Amin Has Served as an Independent Director Since 2015 and Succeeds Jonathan Peacock Following…
Evaxion Biotech Appoints Lars Holtug to the Board of Directors
COPENHAGEN, Denmark, May 26, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage…
Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent
– Clinical study evaluating the well-known health claims of beta glucan and its potentially beneficial…
Dyadic announces development of COVID-19 Vaccine in India
In collaboration with Syngene International Ltd. JUPITER, Fla., May 26, 2021 (GLOBE NEWSWIRE) — Dyadic…
Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference
PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s…
Connect Biopharma to Participate at the Jefferies Virtual Healthcare Conference
SAN DIEGO and TAICANG, SUZHOU, China, May 26, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
Applied Molecular Transport to Present at Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Applied Molecular Transport Inc. (Nasdaq:…
AmMax Bio Announces First Patient Enrolled in Phase 2 Trial of AMB-05X For Tenosynovial Giant Cell Tumor (TGCT)
Novel Intra-articular Drug Delivery to Minimize Systemic Toxicity Associated with Currently Available TGCT Therapies First…